D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Alibaba
BABA
|
+$420M |
| 2 |
Oracle
ORCL
|
+$406M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$307M |
| 4 |
Apple
AAPL
|
+$306M |
| 5 |
Meta Platforms (Facebook)
META
|
+$292M |
Top Sells
| 1 |
Amazon
AMZN
|
+$673M |
| 2 |
AET
Aetna Inc
AET
|
+$378M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$285M |
| 4 |
AT&T
T
|
+$255M |
| 5 |
NVIDIA
NVDA
|
+$243M |
Sector Composition
| 1 | Technology | 19.62% |
| 2 | Consumer Discretionary | 15.28% |
| 3 | Healthcare | 14.47% |
| 4 | Financials | 9.86% |
| 5 | Industrials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Credicorp
BAP
$21B
| $21.2M | 0.03% |
95,817
-5,591
| -6% | -$1.24M |
|
|
HDP
502
DELISTED
Hortonworks, Inc.
HDP
| $21.2M | 0.03% |
1,469,880
+1,425,283
| +3,196% | +$20.6M |
|
|
MGLN
503
DELISTED
Magellan Health Services, Inc.
MGLN
| $21.1M | 0.03% |
371,196
+26,628
| +8% | +$1.51M |
|
|
ACIA
504
DELISTED
Acacia Communications, Inc. Common Stock
ACIA
| $21.1M | 0.03% |
555,351
+342,037
| +160% | +$13M |
|
505
Hubbell
HUBB
$23.5B
| $21.1M | 0.03% |
212,057
-67,734
| -24% | -$6.73M |
|
506
Dynavax Technologies
DVAX
$1.14B
| $21M | 0.03% |
2,294,520
+192,770
| +9% | +$1.76M |
|
|
ATSG
507
DELISTED
Air Transport Services Group, Inc.
ATSG
| $21M | 0.03% |
919,772
+118,056
| +15% | +$2.69M |
|
|
SYNH
508
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $20.9M | 0.03% |
531,991
+120,829
| +29% | +$4.75M |
|
509
Royal Bank of Canada
RY
$203B
| $20.9M | 0.03% |
304,588
-74,899
| -20% | -$5.13M |
|
510
Eastman Chemical
EMN
$7.47B
| $20.8M | 0.03% |
284,368
+281,063
| +8,504% | +$20.5M |
|
511
GSK
GSK
$81.5B
| $20.5M | 0.03% |
+429,680
| New | +$20.5M |
|
512
COPT Defense Properties
CDP
$3.45B
| $20.5M | 0.03% |
+975,339
| New | +$20.5M |
|
|
RTEC
513
DELISTED
Rudolph Technologies Inc
RTEC
| $20.5M | 0.03% |
999,906
-30,566
| -3% | -$626K |
|
514
iShares Core MSCI Emerging Markets ETF
IEMG
$105B
| $20.4M | 0.03% |
432,163
-591,090
| -58% | -$27.9M |
|
|
FSAC
515
DELISTED
Federal Street Acquisition Corp. Common Stock
FSAC
| $20.4M | 0.03% |
+1,990,000
| New | +$20.4M |
|
516
First American
FAF
$6.74B
| $20.3M | 0.03% |
455,420
-169,870
| -27% | -$7.58M |
|
517
BioMarin Pharmaceuticals
BMRN
$10.5B
| $20.1M | 0.03% |
235,769
+137,558
| +140% | +$11.7M |
|
518
General Mills
GIS
$26.7B
| $20.1M | 0.03% |
515,510
+365,577
| +244% | +$14.2M |
|
519
Jazz Pharmaceuticals
JAZZ
$7.7B
| $20M | 0.03% |
161,715
+63,100
| +64% | +$7.82M |
|
520
SM Energy
SM
$3.14B
| $20M | 0.03% |
1,294,861
+53,454
| +4% | +$827K |
|
|
NEWR
521
DELISTED
New Relic, Inc.
NEWR
| $20M | 0.03% |
247,063
-27,569
| -10% | -$2.23M |
|
522
Taylor Morrison
TMHC
$6.89B
| $19.9M | 0.03% |
1,250,665
+42,959
| +4% | +$683K |
|
523
Affiliated Managers Group
AMG
$6.6B
| $19.8M | 0.03% |
202,880
-67,250
| -25% | -$6.55M |
|
524
Henry Schein
HSIC
$8.17B
| $19.8M | 0.03% |
320,989
+311,786
| +3,388% | +$19.2M |
|
525
Integra LifeSciences
IART
$1.2B
| $19.7M | 0.03% |
435,989
-17,040
| -4% | -$769K |
|